Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Claims Drawing Regulatory Attention FDA has indicated that compounded products generally should not be promoted using claims that: Suggest FDA approval Imply therapeutic equivalence Claim generic status without approval Guarantee clinical outcomes Misrepresent safety profiles Compare performance to approved products without evidence Marketing communications must be carefully reviewed to avoid misleading representations
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 digital issues and online access to articles 118,99 per year only 9,92 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Understanding Antioxidants and Peptides Antioxidants can be put in three different buckets
Eating strategy: Survival mode
47(4): 75860 Panzetta G, Bonadonna G, Giovene P, et al
In practice, only a minuscule fraction of participants had small vessel disease, limiting interpretability
US$ 26.28
US$ 26.27
US$ 21.60
US$ 21.90
